ArticlePDF Available

GOJI BERRY (LYCIUM BARBARUM) TEA MAY AFFECT NEGATIVELY SOME PARAMETERS IN WISTAR RATS

Authors:
  • Universidade de Marília - Medicina

Abstract and Figures

Lycium barbarum (Goji berry) is a plant commonly used in folk medicine with properties that include antiaging, anticancer, antioxidant, antidiabetes, antihyperlipidemia, antithrombosis, improvement of immune response and reduction of infections. The use of Goji Berry (GB) tea is becoming very popular in Brazil mainly with the purpose of reduction the body weight and improvement of glycaemia and lipid profile. The aim of this study was to investigate the effects of goji berry (GB) tea on the metabolic profile and some aspects of the behavior of Wistar rats. Animals were randomly divided in control group and group treated with GB tea. At the end of 60 days the animals performed the Elevated Plus Maze for behavioral assessment in order to evaluate the anxiety index. After that, blood was collected to the evaluation of the biochemical profile. Our results showed that goji berry tea may assist in reducing the body weight gain even without reducing the consumption of food but significantly increased glycemic levels and did not interfere in the lipid profile as well as in the visceral fat. GB tea also increased the anxiety behavior in the animals of GB group. The increase in the glycaemia contradicts the findings in the literature probably because the composition of the tea is different from the pure GB fruit or polysaccharides. We suggest more studies in order to evaluate the different products of GB that are available in the supermarkets once they may not bring the desired effects.
Content may be subject to copyright.
www.wjpr.net Vol 5, Issue 7, 2016.
42
Barbalho et al. World Journal of Pharmaceutical Research
GOJI BERRY (LYCIUM BARBARUM) TEA MAY AFFECT
NEGATIVELY SOME PARAMETERS IN WISTAR RATS
Patrícia C. S Bueno1, Sandra Maria Barbalho1,2*, Ana Elisa Martins Ferreira1,
Gleydson Bezerra da Mota Junior1, Luis Henrique Lemos Dos Santos1, Claudemir
Gregório Mendes1
1Department of Biochemistry and Pharmacology, School of Medicine, University of Marília,
Av. Higino Muzzi Filho 1001, Marília 15525-902, SP, Brazil.
2Department of Biochemistry and Nutrition, Faculty of Food Technology of Marília
(FATEC), Av. Castro Alves, 62, Marília 17506-000, SP, Brazil.
ABSTRACT
Lycium barbarum (Goji berry) is a plant commonly used in folk
medicine with properties that include antiaging, anticancer,
antioxidant, antidiabetes, antihyperlipidemia, antithrombosis,
improvement of immune response and reduction of infections. The use
of Goji Berry (GB) tea is becoming very popular in Brazil mainly with
the purpose of reduction the body weight and improvement of
glycaemia and lipid profile. The aim of this study was to investigate
the effects of goji berry (GB) tea on the metabolic profile and some
aspects of the behavior of Wistar rats. Animals were randomly divided
in control group and group treated with GB tea. At the end of 60 days
the animals performed the Elevated Plus Maze for behavioral
assessment in order to evaluate the anxiety index. After that, blood was
collected to the evaluation of the biochemical profile. Our results
showed that goji berry tea may assist in reducing the body weight gain even without reducing
the consumption of food but significantly increased glycemic levels and did not interfere in
the lipid profile as well as in the visceral fat. GB tea also increased the anxiety behavior in
the animals of GB group. The increase in the glycaemia contradicts the findings in the
literature probably because the composition of the tea is different from the pure GB fruit or
polysaccharides. We suggest more studies in order to evaluate the different products of GB
that are available in the supermarkets once they may not bring the desired effects.
World Journal of Pharmaceutical Research
SJIF Impact Factor 6.805
Volume 5, Issue 7, 42-52. Research Article ISSN 2277 7105
*Corresponding Author
Prof. Dr. Sandra Maria
Barbalho
Department of Biochemistry
and Pharmacology, School
of Medicine, University of
Marília, Av. Higino Muzzi
Filho 1001, Marília 15525-
902, SP, Brazil.
Article Received on
23 April 2016,
Revised on 14 May 2016,
Accepted on 05 June 2016
DOI: 10.20959/wjpr20167-6484
www.wjpr.net Vol 5, Issue 7, 2016.
43
Barbalho et al. World Journal of Pharmaceutical Research
KEY WORDS: Lycium barbarum, glycaemia, lipids, weight, anxiety, Wistar rats.
INTRODUCTION
Goji berry (GB) or wolfberry is the small and sweet fruit of the plant Lycium barbarum
(Solanacea) that has been used traditionally as medicinal food in many countries. Its
medicinal properties include antiaging, anticancer, antioxidant, antihyperlipidemia,
antithrombosis, protection against experimental ulcerative colitis, improvement of immune
response and reduction of infections.[1-5]
This plant is also considered as therapy for diabetes and other metabolic conditions, once it
may enhance metabolic rate and may reduce body-weight gains in animal and human models.
Authors have shown its effects also on reduction of the waist circumference. Besides other
components, the presence of water-soluble bioactive polysaccharides in goji fruit may
contribute to the health benefits as anti-fatigue activity due to the reduction of lipid
peroxidation and increase in antioxidant enzyme activities as well as exhibits
hepatoprotective effects. Other authors have shown improvement of intrusive memory related
cognition defect, reduction of the apoptosis in the hippocampus and recovery for the
neurogenesis as well as anti-hypertension and anti-hyperglycemic effects.[6-11]
The chemical composition of GB shows that it mainly contains polysaccharides, vitamins,
amino acids, taurine, alkaloids, and volatile oil.[12] Nardi et al[13] found that GB presents
significant phenolic and flavonoids content.
The use of GB is becoming very popular in Brazil mainly with the purpose of reduction of
body weight and improvement in the lipid and glycaemia profile. Population frequently
consumes this plant as tea and this consume has increased year by year. Thus, the aim of this
study was to investigate the effects of a goji berry formulation on the metabolic profile and
some aspects of the behavior of Wistar rats.
MATERIALS AND METHODS
Preparation of the solution: The product used in this work is commonly found in Brazilian
supermarkets and pharmacies as Goji Berry tea and it is sold in packaging with 200 grams
of powder. The composition of the formulation is goji berry extract, polydextrose, rice flour,
fructooligosaccharide, vitamin and mineral mix, gelatin, hydrolyzed collagen, citric acid,
aroma identical to natural raspberry, antiwetting agent tricalcium phosphate, and stevia.
www.wjpr.net Vol 5, Issue 7, 2016.
44
Barbalho et al. World Journal of Pharmaceutical Research
We used 40g of the powder in 500mL of cold water in order to prepare a solution that was
used ad libitum for 60 days in the treated group.
Rat groups: This experiment was approved by the Animal Research Ethics Committee of the
University of Marília (UNIMAR, Marília, SP, Brazil). Twenty female Wistar weighing
approximately 100g to 120g were used and kept in the vivarium at the Medical School of
Marilia - UNIMAR. The rats were housed in collective cages under a dark/light cycle of 12
hours, room temperature of 22 ± 2°C, and relative air humidity of 60 ± 5%. During the
experimental period, the animals were fed and watered ad libitum; and were cared for
according to the recommendations of the Canadian Council’s “Guide for the care and use of
experimental animals”. Female rats were used because most people who use this kind of
product to reduce body weight are women.
After a period of 7 days of acclimation to laboratory conditions, the animals were divided
randomly in the experimental groups, which were identified according to the treatment they
would receive
G1: Control group, treated with rat feed and water ad libitum.
G2: Group treated with rat feed and GB solution ad libitum.
After a period of 60 days, the animals were euthanized with a lethal intraperitoneal injection
of 200 mg/Kg of thiopental. After death, blood samples were drawn from the vena cava to
determine the biochemical profile: total cholesterol, high density lipoprotein (HDL-c),
triglycerides, glycaemia, aspartate aminotransferase (AST) and alanine aminotransferase
(ALT). The glucose and lipid levels were measured in mg/dL; AST and ALT in U/L.
Atherogenic Index (AI) and Protection Index (PI) were evaluated after Schulpis, Karikas[14]
and Munshi, Joshi, Rane.[15]
Behavioral testing
After 60 days of the experimental protocol, the animals underwent the Elevated Plus Maze
for behavioral assessment in order to evaluate the anxiety index in animals from the Control
group and the animals treated with GB. For this protocol we used the model according to
Boerngen-Lacerda et al[16] and Blanchard et al.[17]
The Elevated Plus Maze is made of wood with two open and opposed arms, measuring 50x10
cm, and two enclosed, with 50 x 10 x 40 cm and with platforms with the same extent of the
www.wjpr.net Vol 5, Issue 7, 2016.
45
Barbalho et al. World Journal of Pharmaceutical Research
open arms, crossing them perpendicularly, which delimits a central area of 10 cm2. The unit
is 50 cm from the ground. Animals were placed in the Elevated Plus Maze for 5 minutes and
were evaluated by analyzing the frequency and the time spent in the center, and in open and
closed arms. We also evaluated the time and frequency of lifting, stretching, diving and self-
cleaning.
Statistical analysis
T-Test and ANOVA were performed for the statistical analysis and the variables were
presented as mean and standard deviation, adopting a level of significance of 5%.
RESULTS
In Table 1 we may see that the animals treated with GB reduced body weight after the
treatment period but they did not decrease food consumption. No differences were found for
visceral fat.
Table: 1. Mean and standard deviation of the food consumption and anthropometric
parameters of the animals of the control group (G1) and the group treated with Goji
berry (G2).
Parameters
G1
G2
Food consumption g/kg
0.491±0.0814
0.497±0.0978
Body weight at the beginning (g)
108.5±17.82
109.4±14.86
Body weight after 60 days (g)
225.7±16.11
210.95±10.34
Visceral fat (g)
3.81±1.54
3.27±1.79
*Level of significance: 5%
In this study, animals treated with GB increased glycemic levels, decreased hepatic enzymes
and did not present changes in the lipid profile (Table 2).
Table 2. Mean and standard deviation of the biochemical profile of the animals of the
control group (G1) and the group treated with Goji berry (G2).
Parameters
G1
G2
p-value
Glycaemia (mg/dL)
154.6±46.06
182.5±45.13
0.03*
Triglycerides (mg/dL)
80.0±28.45
74.9±21.87
0.32
Total cholesterol (mg/dL)
61.4±7.64
59.9±7.70
0.33
HDL-c (mg/dL)
24.0±2.40
23.2±1.75
0.20
AST (U/L)
124.5±92.60
76.0±12.64
0.05*
ALT (U/L)
58.1±10.29
46.8±4.24
0.09*
HDL-c: High density lipoprotein; AST: aspartate aminotransferase and alanine ALT:
aminotransferase. *Level of significance: 5%.
www.wjpr.net Vol 5, Issue 7, 2016.
46
Barbalho et al. World Journal of Pharmaceutical Research
The treatment with GB did not interfere in the atherogenic index (Table 3).
Table 3 - Atherogenic Index (AI) in the group control group (G1) and group treated
with Goji berry (G2).
Parameter
G1
G2
Atherogenic index (%)
1.56
1.58
The Protection index for G2 exhibited null value for the group treated with GB when
compared to the control group.
Figure 1 shows that the weight gain in the animal groups. We may see in this figure that the
animals from control group gained weight more evenly during the experiment when
compared to the animals of GB group. Significant values were found when comparing both
groups.
Figure 1. Weight gain in the animals from control group (G1) and group treated with
Goji berry (G2) during the 60 days of the study.
Table 4. Results for the behavior (time and frequency) in the Elevated Pluz Maze in G1
(control group) and G2 (group treated with GB).
Behavior
G1
G2
p-value
Time in the open arm
35.07 ±26.23
57.29±17.46
0.019*
www.wjpr.net Vol 5, Issue 7, 2016.
47
Barbalho et al. World Journal of Pharmaceutical Research
Frequency in the open arm
3.60 ± 2.22
5.10±1.37
0.042*
Time in the close arm
196.60 ±31.49
158.90±23.16
0.003*
Frequency in the close arm
5.20 ±2.10
6.90±2.28
0.050*
Time in the center
68.33±30.74
83.80±27.22
0.124
Frequency in the center
7.20 ±3.22
9.90±2.47
0.024*
Time of lifting
2.22±0.81
3.31±0.72
0.043*
Frequency of lifting
12.8 ±5.25
10.70±4.97
0.180
Time of strenghing
2.22±1.04
3.31±1.58
0.043*
Frequency of strenghing
13.9±5.70
21.20±10.13
0.031*
Time of diving
0.66±0.51
1.13± 0.69
0,050*
Frequency of diving
4.1±3.21
7.10±4.36
0.048*
Time of self-cleaning
2.42±0.67
1.75±0.79
0.028*
Frequency of self-cleaning
16.8±5.57
11.90±4.84
0.025*
Frequency was measured in %. *Level of significance: 5%.
Table 4 shows the results for the group of animals underwent the Elevated Plus Maze showed
that G2 increased the anxiety behavior for all analyzed parameters.
DISCUSSION
Our results showed that GB solution may assist in reducing the body weight gain even
without reducing the consumption of food but significantly increased glycemic levels and did
not interfere in the lipid profile as well as in the visceral fat.
Most studies show that GB is related to hypoglycemic effects mainly when using
polysaccharides (GBP) extracted from the fruit. Cai et al[18] showed these polysaccharides
decreased postprandial glycaemia at a dose of 300 mg/day for 3 months and increased HDL-
c levels in patients with type 2 diabetes. Authors also found that the GBP decreased
postprandial glycaemia while sustaining postprandial release of insulin suggesting
stimulation of insulin secretion and sensitivity. These hypoglycemic findings were observed
in animal models by many other authors.[19-21] Gao et al[22] and Xi et al[23] showed that the
root bark of Lycium barbarum decreased significantly the action of the peroxisome
proliferator-activated receptors (PPAR)-γ that is an remarkable target for the treatment of
type 2 diabetes mellitus.
Other interesting findings in the literature is that GBP may also reduce the production of
adipokines as Tumor Necrosis Factor-α, leptin and interleukin-6 that are involved in the
development of insulin resistance and subsequent type 2 diabetes.[18, 24]
www.wjpr.net Vol 5, Issue 7, 2016.
48
Barbalho et al. World Journal of Pharmaceutical Research
Other researchers found improvement in the lipid profile with important reduction in the
levels of triglycerides, total cholesterol, and LDL-c together with increase in the HDL-c.[19, 25]
GB is known as being the richest natural sources of zeaxanthin, and exhibits a high amount of
antioxidant activity.[12, 26] Tang et al[27 compared the effects of zeaxanthin and lutein in GB
and showed that both components may mimic GB effects on the activation of AMPK,
thioredoxin, and Mn Superoxide dismutase, normalizing cellular reactive oxygen species.
The presence of these antioxidants as well as polysaccharides, vitamins, amino acids, taurine,
phenolic content, flavonoids and volatile oil[12, 13] may be also related to the effects in the
lipid and glycemic profile. Antioxidants are also related with cardiovascular protection. We
did not observe similar results probably because the product used in our research was not
pure GB extract.
Our results in the body weight are corroborated by some studies. GB consumption may
increase metabolic rate and may reduce the waist circumference in health adult humans.[11]
Xiao et al[28] studied obese animals fed a high-fat diet and observed significant reduction in
the body weight when compared with the control animals.[2] Tao, He[29] observed reduction in
mice body weight after using a low and a high-dose GBP.
The levels of hepatic enzymes (AST and ALT) decreased after using GB solution. Elevation
of these enzymes levels would indicate destruction of liver cells, however, our results do not
show increase in these enzymes.[30]
Paul, Nance, Amagase[31] studied the effects of GP in a double-blind, placebo-controlled
human clinical trials and showed significant improvements in neurological/psychological
performance and overall feelings of health and well-being. Chang et al[32] found that these
polysaccharides may effective in reducing depression-like behavior and the antidepressant
action may be related to an enhance in the synaptic plasticity. Our results showed that the
effects of the formulation used in this work increased anxiety in the rats. Animals performing
the elevated plus maze exhibit a behavior known as risk assessment, which may be related to
hypervigilance by anxious individuals and may be an anticipation of a potential danger.
Anxious individuals tend to anticipate a proactive behavior.[16, 17] We did not find studies
including GB and this kind of environment model.
Several studies have shown that GB indices improvement in the glycaemia, lipid profile and
body weight in humans and animal models. Our results showed beneficial effects only on the
www.wjpr.net Vol 5, Issue 7, 2016.
49
Barbalho et al. World Journal of Pharmaceutical Research
percentage of weight gain and on the other hand, we observed an increase in blood glucose.
These different results in the literature could be explained because the solution was prepared
in a commercial product instead of a pure GB extract. Therefore, we suggest more studies in
order to evaluate the different products with GB that are available in the supermarkets and
pharmacies once they may not bring the desired effects. Therefore, consumers should be
careful when purchasing a commercial product because it can bring negative health effects.
AUTHOR DISCLOSURE STATMENTS
No competing financial interests exist. There is no conflict of interest for any author.
REFERENCES
1. Zhao L, Wu H, Zhao A, Lu H, Sun W, Ma C, Yang Y, Xin X, Zou H, Qiu M, Jia W. The
in vivo and in vitro study of polysaccharides from a two-herb formula on ulcerative colitis
and potential mechanism of action. J Ethnopharmacol, 2014 Apr 11; 153(1): 151-9. doi:
10.1016/j.jep.2014.02.008.
2. Ren Z, Na L, Xu Y, Rozati M, Wang J, Xu J, Sun C, Vidal K, Wu D, Meydani SN.
Dietary supplementation with lacto-wolfberry enhances the immune response and reduces
pathogenesis to influenza infection in mice. J Nutr, 2012 Aug; 142(8): 1596-602. doi:
10.3945/jn.112.159467.
3. Potterat O. Goji (Lycium barbarum and L. chinense): phytochemistry, pharmacology and
safety in the perspective of traditional uses and recent popularity. Planta Med, 2010; 76:
719.
4. Chang RC, So KF. Use of anti-aging herbal medicine, Lycium barbarum, against aging-
associated diseases: what do we know so far? Cell Mol Neurobiol, 2008; 28: 64352.
5. Du X, Wang J, Niu X, Smith D, Wu D, Meydani SN. Dietary wolfberry supplementation
enhances the protective effect of flu vaccine against influenza challenge in aged mice. J
Nutr, 2014 Feb; 144(2): 224-9. doi: 10.3945/jn.113.183566.
6. Zhang X, Yang X, Lin Y, Suo M, Gong L, Chen J, Hui R. Anti-hypertensive effect
of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA
sONE in a rat model of salt-sensitive hypertension. Int J Clin Exp Pathol, 2015 Jun 1;
8(6): 6981-7. eCollection 2015.
7. Yuan Y, Wang YB, Jiang Y, Prasad KN, Yang J, Qu H, Wang Y, Jia Y, Mo H, Yang B.
Structure identification of a polysaccharide purified from Lycium barbarium fruit. Int J
Biol Macromol, 2016 Jan; 82: 696-701. doi: 10.1016/j.ijbiomac.2015.10.069.
www.wjpr.net Vol 5, Issue 7, 2016.
50
Barbalho et al. World Journal of Pharmaceutical Research
8. Zhao R, Cai Y, Shao X, Ma B. Improving the activity of Lycium
barbarum polysaccharide on sub-health mice. Food Funct, 2015 Jun; 6(6): 2033-40. doi:
10.1039/c4fo01108b.
9. Liu Y, Cao L, Du J, Jia R, Wang J, Xu P, Yin G. Protective effects of Lycium
barbarum polysaccharides against carbon tetrachloride-induced hepatotoxicity in
precision-cut liver slices in vitro and in vivo in common carp (Cyprinus carpio L.). Comp
Biochem Physiol C Toxicol Pharmacol, 2015 Mar; 169: 65-72. doi:
10.1016/j.cbpc.2014.12.005
10. Tang HL, Chen C, Wang SK, Sun GJ. Biochemical analysis and hypoglycemic activity of
a polysaccharide isolated from the fruit of Lycium barbarum L. Int J Biol Macromol.
2015; 77: 235-42. doi: 10.1016/j.ijbiomac.2015.03.026. Epub 2015 Mar 26.
11. Amagase H, Nance DM. Lycium barbarum increases caloric expenditure and decreases
waist circumference in healthy overweight men and women: pilot study. J Am Coll Nutr,
2011 Oct; 30(5): 304-9.
12. Zhou Jing, Li Guanghua. Study review on chemical composition and pharmacological
effects of barbary wolfberry. Journal of Liaoning University of Traditional Chinese
Medicine, 2009; 11(6): 93-95.
13. Geisson Marcos Nardi, Adriana Graziele Farias Januario, Cassio Geremia Freire,
Fernanda Megiolaro, Kétlin Schneider, Marlene Raimunda Andreola Perazzoli, Scheley
Raap Do Nascimento, Ana Cristina Gon, Luísa Nathália Bolda Mariano, Glauber
Wagner, Rivaldo Niero, Claudriana Locatelli. Anti-inflammatory Activity of Berry Fruits
in Mice Model of Inflammation is Based on Oxidative Stress Modulation.
Pharmacognosy Res, 2016 March; 8(Suppl 1): S42S49. doi: 10.4103/0974-8490.178642
14. Schulpis K, Karikas GA. Serum cholesterol and triglyceride distribution in 7767 school-
aged Greek children. Pediatrics, 1998 May; 101(5): 861-4.
15. Munshi RP, Joshi SG1, Rane BN. Development of an experimental diet model
in rats to study hyperlipidemia andinsulin resistance, markers for coronary heart disease.
Indian J Pharmacol, 2014 May-Jun; 46(3): 270-6. doi: 10.4103/0253-7613.132156.
16. Blanchard CD, Griebel G, Blanchard RJ. Mouse defensive behaviors: pharmacological
and behavioral assays for anxiety and panic. Neuroscience and Biobehavioral Reviews,
2001; 25: 205- 218.
17. Boerngen-Lacerda RB, Souza-Formigoni ML, Souza O. Does the increase in the
locomotion induced by the ethanol indicate its stimulant or anxiolytic properties?
Pharmacology, Biochemistry and Behavior, 2000; 67: 225-232.
www.wjpr.net Vol 5, Issue 7, 2016.
51
Barbalho et al. World Journal of Pharmaceutical Research
18. Cai H, Liu F, Zuo P, Huang G, Song Z, Wang T, Lu H, Guo F, Han C, Sun G. Practical
Application of Antidiabetic Efficacy of Lycium barbarum Polysaccharide in Patients with
Type 2 Diabetes. Med Chem, 2015; 11(4): 383-90.
19. Jin, M.L.; Huang, Q.S.; Zhao, K.; Shang, P. Biological activities and potential health
benefit effects of polysaccharides isolated from Lycium barbarum L. Int J Biol
Macromol, 2013; 54: 16-23.
20. Ma, M.; Liu, G.H.; Yu, Z.H.; Chen, G.; Zhang, X. Effect of the Lycium barbarum
polysaccharides administration on blood lipid metabolism and oxidative stress of mice
fed high-fat diet in vivo. Food Chem., 2009; 113(4): 872-7.
21. Li, X.M. Protective effect of Lycium barbarum polysaccharides on streptozotocin-
induced oxidative stress in rats. Int J Biol Macromol, 2007; 40(5): 461-5.
22. Gao D, Zhang Y, Yang F, Lin Y, Zhang Q, Xia Z. In vitro Screening and Evaluation of
37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-
Activated Receptors-γ. Pharmacogn Mag, 2016 Apr-Jun; 12(46): 120-7. doi:
10.4103/0973-1296.177909
23. Xie LW, Atanasov AG, Guo DA, Malainer C, Zhang JX, Zehl M, Guan SH, Heiss EH,
Urban E, Dirsch VM, Kopp B. Activity-guided isolation of NF-κB inhibitors and PPARγ
agonists from the root bark ofLycium chinense Miller. J Ethnopharmacol, 2014 Mar 28;
152(3): 470-7. doi: 10.1016/j.jep.2014.01.029.
24. Cai, H.Z.; Liu, F.K.; Lu, H.X.; Guo, F.; Hu, L.J.; Han, C.; Sun, G.J. Short-Term
Intervention of Lycium barbarum Polysaccharide on Type 2 Diabetes. Food science,
2013; 33(13): 259-62.
25. Cheng, D.; Kong, H. The effect of Lycium barbarum polysaccharide on alcohol-induced
oxidative stress in rats. Molecules, 2011; 16(3): 2542-50.
26. Li XM, Ma YL, Liu XJ. Effect of the Lycium barbarum polysaccharides on age-related
oxidative stress in aged mice. J Ethnopharmacol, 2007; 111: 50411.
27. Tang L, Zhang Y, Jiang Y, Willard L, Ortiz E, Wark L, Medeiros D, Lin D. Dietary
wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of
diabetes. Exp Biol Med (Maywood), 2011 Sep; 236(9): 1051-63. doi:
10.1258/ebm.2011.010400.
28. Xiao J, Xing F, Huo J, Fung ML, Liong EC, Ching YP, Xu A, Chang RC, So KF, Tipoe
GL. Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-
alcoholic steatohepatitis rats and cellular steatosis model. Sci Rep, 2014 Jul 7; 4: 5587.
doi: 10.1038/srep05587.
www.wjpr.net Vol 5, Issue 7, 2016.
52
Barbalho et al. World Journal of Pharmaceutical Research
29. Tao Tang, Bixiu He. Treatment of D-Galactose Induced Mouse Aging
with Lycium Barbarum Polysaccharides and Its Mechanism Study. Afr J Tradit
Complement Altern Med, 2013; 10(4): 1217.
30. Cai C, Cao Z, Loughran PA, Kim S, Darwiche S, Korff S, Billiar TR. Mast cells play a
critical role in the systemic inflammatory response and end-organ injury resulting from
trauma. J Am Coll Surg, 2011; 213(5): 604-615.
31. Paul Hsu CH1, Nance DM, Amagase H. A meta-analysis of clinical improvements of
general well-being by a standardized Lycium barbarum. J Med Food, 2012 Nov; 15(11):
1006-14. doi: 10.1089/jmf.2012.0013.
32. Zhang E, Yau SY, Lau BW, Ma H, Lee TM, Chang RC, So KF. Synaptic plasticity, but
not hippocampal neurogenesis, mediated the counteractive effect of wolfberry
on depression in rats (1). Cell Transplant, 2012; 21(12): 2635-49. doi:
10.3727/096368912X655181.
... In Brazil, goji berries are commonly used for reduction of body weight and in the treatment of dyslipidemia and diabetes and its consumption is increasing year by year due to these medicinal applications. [5] Natural plants or its products are related to low toxicity to the liver and kidney and may work as an alternative for prevention or treatment of several diseases since the available allopathic therapies are usually associated with high costs and different side effects that bring discomfort for the patients. Due to the several positive effects that plant may promote in health, the objective of this review was to investigate the properties and applications of goji berry. ...
Article
Full-text available
Background: Many fruits have been used as nutraceuticals because the presence of bioactive molecules that play biological activities. Objective: The present study was designed to compare the anti‑inflammatory and antioxidant effects of methanolic extracts of Lycium barbarum (GOJI), Vaccinium macrocarpon (CRAN) and Vaccinium myrtillus (BLUE). Materials and Methods: Mices were treated with extracts (50 and 200 mg/kg, p.o.), twice a day through 10 days. Phytochemical analysis was performed by high‑performance liquid chromatography. Antioxidant activity was determine by 2,2‑diphenyl‑1‑picrylhydrazyl (DPPH) assay, reducing power, lipid peroxidation thiobarbituric acid reactive substances (TBARS), reduced glutathione (GSH) and catalase (CAT) activity. Anti‑inflammatory activity was evaluated by paw edema followed by determination of myeloperoxidase (MPO) and TBARS. Results: High amount of phenolic compounds, including rutin, were identified in all berries extracts. However, quercetin was observed only in BLUE and CRAN. GOJI presents higher scavenging activity of DPPH radical and reducing power than BLUE and CRAN. The extracts improved antioxidant status in liver; BLUE showed the largest reduction (75.3%) in TBARS when compared to CRAN (70.7%) and GOJI (65.3%). Nonetheless, CAT activity was lower in BLUE group. However, hepatic concentrations of GSH were higher in animals treated with GOJI rather than CRAN and BLUE. Despite all fruits caused a remarkable reduction in paw edema and TBARS, only BLUE and CRAN were able to reduce MPO. Conclusion: These results suggest that quercetin, rutin, or other phenolic compound found in these berry fruits extracts could produce an anti‑inflammatory response based on modulation of oxidative stress in paw edema model.
Article
Full-text available
Background: Peroxisome proliferator-activated receptors (PPAR)-γ is widely used as an attractive target for the treatment of type 2 diabetes mellitus. Thiazolidinediones, the agonists of PPARγ, has been popularly utilized as insulin sensitizers in the therapy of type 2 diabetes whereas numerous severe side-effects may also occur concomitantly. Objective: The PPARγ activation activity of different polar extracts, including petroleum ether, ethyl acetate, n-butanol, residual of ethanol, the precipitate part of water and the supernatant of water extracts, from 37 traditional Chinese medicines were systematically evaluated. Materials and methods: HeLa cells were transiently co-transfected with the re-constructed plasmids of GAL4-PPARγ-ligand binding domain and pGL4.35. The activation of PPARγ by different polarity extracts were evaluated based on the PPARγ transactivation assay and rosiglitazone was used as positive control. Results: Seven medicines (root bark of Lycium barbarum, Anoectochilus sroxburghii, the rhizome of Phragmites australis, Pterocephalus hookeri, Polygonatum sibiricum, fruit of Gleditsia sinensis, and Epimedium brevicornu) were able to significantly activate PPARγ. Conclusion: As seven medicines were able to activate PPARγ, the anti-diabetic activity of them is likely to be mediated by this nuclear receptor. Summary: Lots of the tested medicinal products had activation effects on activating PPARγEthyl acetate extracts of root bark of L.barbarum, rhizome of P.saustralis and fruit of G.siasinensis showed good PPARγ activation effect similar or higher than that of positive control, 0.5 μg/mL rosiglitazonePetroleum ether extracts of A.roxburghii, P. hookeri, P. sibiricum, E.brevicornu also can significantly activate PPARγ, the effects of them were higher than t0.5 μg/mL rosiglitazoneSchisandra chinensis (Turcz.) Baill., the fruit Cornus officinalis Siebold and Zucc., Alisma plantago-aquatica L. and the root of Trichosanthes Kirilowii Maxim., traditional anti-diabetic mediciness in China, had no effects on the activation of PPARγ. Abbreviations used: PPARγ: Peroxisome Proliferator-activated Receptors-γ, TCMs: Traditional Chinese medicines, TZDs: Thiazolidinediones, LBD: Ligand binding domain, DMSO: Dimethyl sulfoxide, FBS: Fetal bovine serum, DMEM: Dulbecco's modified Eagle's medium.
Article
Full-text available
Lycium barbarum polysaccharide (LBP) has been traditionally used in Chinese medicine as a chief ingredient of L. barbarum (wolf berry/goji berry) for the treatment of various diseases with the symptom of frequent drinking and urination. The study was a randomized, controlled clinical trial. A total of 67 patients with type 2 diabetes (30 in control group and 37 in LBP group) participated in this prospective, randomized, double-blind study (administration at 300mg/day body weight). In order to observe the hypoglycemic and lipid-lowering activity of LBP in patients with type 2 diabetes after dinner, varieties were tested between control and LBP intervention groups in 3 months. Although, the study had small sample size and short follow-up, significant findings were got. The results of our study indicated a remarkable protective effect of LBP in patients with type 2 diabetes. Serum glucose decreased significantly and insulinogenic index increased during OMTT after 3 months administration by LBP. LBP also increased HDL levels in patients with type 2 diabetes. It had more obvious hypoglycemic efficacy for those people who did not take any hypoglycemic medicine compared to patients with hypoglycemic medicines. This study showed that LBP should be a good potential treatment aided-agent for type 2 diabetes.
Article
Full-text available
This study aimed to investigate the possible therapeutic effects and active components of Lycium barbarum polysaccharides (LBP) on a high fat diet-induced NASH rat model. We induced NASH in a rat model by voluntary oral feeding with a high-fat diet ad libitum for 8 weeks. After 8 weeks, 1 mg/kg LBP was orally administered for another 4 weeks with a high-fat diet. When compared with NASH rats treated for 12 weeks, therapeutic LBP treatment for 4 weeks during 12 weeks of NASH induction showed ameliorative effects on: (1) increased body and wet liver weights; (2) insulin resistance and glucose metabolic dysfunction; (3) elevated level of serum aminotransferases; (4) fat accumulation in the liver and increased serum free fatty acid (FFA) level; (5) hepatic fibrosis; (6) hepatic oxidative stress; (7) hepatic inflammatory response; and (8) hepatic apoptosis. These improvements were partially through the modulation of transcription factor NF-κB, MAPK pathways and the autophagic process. In a palmitate acid-induced rat hepatocyte steatosis cell-based model, we also demonstrated that l-arabinose and β-carotene partially accounted for the beneficial effects of LBP on the hepatocytes. In conclusion, LBP possesses a variety of hepato-protective properties which make it a potent supplementary therapeutic agent against NASH in future clinical trials.
Article
The water-soluble bioactive polysaccharides can contribute to the health benefits of Lycium barbarium fruit. However, the structure characteristics of these polysaccharides remain unclear yet. An important polysaccharide (LBPA) was isolated and purified from L. barbarium in this work. It was identified by chemical and spectroscopic methods as arabinogalactan with β-D-(1→6)-galactan as backbone, which was different to any reported polysaccharides from this species before. This arabinogalactan was comprised of Araf, Galp, GlcpA and Rhap with a molar ratio of 9.2:6.6:1.0:0.9. The side chains, including α-L-Araf-(1→, α-L-Araf-(1→5)-α-L-Araf-(1→, β-L-Araf-(1→5)-α-L-Araf-(1→ and α-L-Rhap-(1→4)-β-D-GlcpA-(1→6)-β-D-Galp-(1→, were linked to β-D-(1→6)-galactan at O-3. The putative structure was drawn as below. The molecular weight was determined to be 470,000g/mol by gel permeation chromatography.
Article
The present study aims to test whether Lycium barbarum L. has anti-hypertensive effect through regulating expression of lncRNA sONE in a rat model of salt-sensitive hypertension. Nine weeks old borderline hypertensive rats (BHRs) were divided into 4 groups receiving high (8% NaCl), medium (0.25% NaCl, as control group), and low salt diet (0.015% NaCl) for 16 weeks, respectively, while the fourth group (high salt + L. barbarum group) fed with high salt diet for 12 weeks, then followed by 8% NaCl and L. barbarum treatment for 4 weeks. Body weight and blood pressure were recorded biweekly. Salt-sensitive hypertension was successfully induced by 12-week high salt diet in BHR model. Blood pressure was significantly increased in the model (P < 0.05), and L. barbarum treatment reversed the elevated blood pressure to normal level. Expression of lncRNA sONE was significantly reduced and eNOS expression level was dramatically improved in the hypertension model rats with the L. barbarum compared with that receiving high salt diet. Our results indicated that L. barbarum L. had anti-hypertensive effect and might lower blood pressure by suppressing the expression of lncRNA sONE in BHR model.
Article
Sub-health has been described as a chronic condition of unexplained deteriorated physiological function, which falls between health and illness and includes fatigue as one of its principal manifestations. Mitochondrial dysfunctions have been discovered in fatigue-type sub-health such as impaired oxidative phosphorylation and mitochondrial damage. In the present study, we evaluated the effects of Lycium barbarum polysaccharide (LBP-4a), a polysaccharide fraction purified from Lycium barbarum, on anti-fatigue in sub-health mice, and the relevant mechanisms were studied. Forty mice were divided into control, model, LBP-4a(L) and LBP-4a(H) groups. Model mice were prepared through compound factors, including forced swim tests, sleep deprivation and wrapping restraint stress tests. After LBP-4a treatment for 4 weeks, the gastrocnemius muscles were obtained for morphological observation and the activities of SOD, GSH-Px and MDA content were detected. Furthermore, mitochondrial membrane potential and Ca(2+) content were measured in isolated skeletal muscle mitochondria. The results showed that LBP-4a could reduce skeletal muscle damage and MDA levels and enhance of SOD and GSH-Px activities compared with the model group. The levels of mitochondrial membrane potential and Ca(2+) were increased in LBP-4a-treated skeletal muscle mitochondria; moreover, the high-dosage group was better than that of the low dosage. In conclusion, LBP-4a exhibited anti-fatigue activity on sub-health mice, and the mechanism was closely correlated with a reduction in lipid peroxidation levels and an increase in antioxidant enzyme activities in skeletal muscle tissue, improving the intracellular calcium homeostasis imbalance and increasing mitochondrial membrane potential. These observations provided the background for the further development of LBP-4a as a type of anti-fatigue therapy used in sub-health treatment.
Article
The protective effects of Lycium barbarum polysaccharides (LBP) against carbon tetrachloride-induced hepatotoxicity in common carp were investigated in vitro and in vivo. Precision-cut liver slices (PCLS), which closely resemble the organ from which they are derived, were employed as an in vitro model system. LBP (0.1, 0.3 and 0.6mg/ml) was added to PCLS culture system before (pre-treatment), after (post- treatment) and both before and after (pre-and post-treatment) the exposure of PCLS to 12mM CCl4. The supernatants and PCLS were collected for biochemical analyses. Results showed that LBP inhibited the elevations of the marker enzymes (GOT, GPT, LDH and AKP) and MDA induced by CCl4 in all LBP treatments, it also enhanced the suppressed antioxidant enzymes (SOD, CAT, GSH-Px, GST) and GSH, in the pre-treatment and pre-and post-treatment. In vivo, fish were fed diets containing LBP at 0.1, 0.5 and 1 % for 60 d before an intraperitoneal injection of 30% CCl4 in olive oil at a volume of 0.05ml/10g body weight. At 72h post injection, blood and liver samples were taken for biochemical analyses. Results showed that LBP at 0.5 and 1 % significantly reduced the levels of GOT, GPT and LDH in the serum, the decreases of the antioxidant enzymes and the increase of MDA in the liver tissue were inhibited markedly. Moreover, the stable free radical diphenylpicrylhydrazyl (DPPH) was used to estimate the radical scavenging activity of LBP. The result showed that LBP even at lower concentration exerted a potent DPPH scavenging activity. Overall results prove the hepatoprotective and antioxidant effects of LBP and support the use of LBP as a hepatoprotective agent in fish. Copyright © 2014 Elsevier Inc. All rights reserved.
Article
Objectives: The objective of this study is to develop an experimental model of hyperlipidemia and insulin resistance (IR), markers of coronary heart disease (CHD) using high fat and high sugar (HFHS) diet and to evaluate the efficacy of the model using atorvastatin, a known antihyperlipidemic drug, pioglitazone, a known insulin sensitizer, and Tinospora cordifolia (Tc), an antidiabetic plant. Materials and Methods: Following Institutional Animal Ethics Committee permission, the study was conducted in male Wistar rats (200-270 g). The model was developed using a high fat (vanaspati ghee: coconut oil, 3:1) oral diet along with 25% fructose (high sugar) added in drinking water over a period of 6 weeks. Atorvastatin (2.1 mg/kg/day), pioglitazone (2.7 mg/kg/day) and Tc (200 mg/kg/day) were administered 3 weeks after initiation of HFHS diet and continued for another 3 weeks. Parameters assessed were weight, lipid profile, fasting blood glucose, insulin, and gastric emptying. Serum malondialdehyde (MDA) and catalase were assessed as markers of oxidative stress. Results: Administration of HFHS diet demonstrated a significant increase in blood glucose, insulin, total and low density lipoprotein cholesterol and triglycerides with a decrease in high density lipoprotein cholesterol. Treatment with test drugs decreased blood sugar, insulin, lipid parameters, increased gastric emptying rate, decreased MDA levels, and catalase activity when compared to HFHS diet group, confirming the efficacy of the model. Atherogenic index of all the test drugs (0.48, 0.57, and 0.53) was significantly lower as compared to HFHS diet group (1.107). Conclusion: This study confirms the development of a diet based cost-effective and time efficient experimental model, which can be used to study two important markers of cardiovascular disease that is, hyperlipidemia and IR and to explore the efficacy of new molecules in CHD.